LGC acquires Berry & Associates

News - LGC has today announced a further strengthening of its nucleic acid chemistry (NAC) offering with the acquisition of Berry and Associates, premier supplier of specialty oligo reagents.

27 September 2018
LGC acquires LINK and strengthens its oligo reagents offering

News - LINK Technologies is a premier supplier of speciality reagents for oligonucleotide synthesis

19 July 2017
LGC acquires Axolabs and invests in GMP manufacturing capacity for therapeutic nucleic acids

News - Moves strengthen existing analytical and bioanalytical drug development service offering

03 April 2017
LGC acquires Prime Synthesis, Inc., and strengthens its supply of oligo synthesis materials

News - PSI products complement existing genomics offering

18 November 2016
LGC acquires Biosearch Technologies and extends its expertise in the qPCR market

News - Acquisition enables enlarged Genomics division to deliver unique product and laboratory services offering for core qPCR and end point PCR applications

15 April 2015
Co-Diagnostics, Inc. and LGC Sign License Agreement for CoPrimer Technology

News - Exclusive license agreement relates to use of CoPrimerâ„¢ technology for both research and commercial applications.

31 October 2018
Innovate UK Awards Grant to MiNA Therapeutics and LGC LINK

News - Funding to develop liver targeted gene activation therapies

02 November 2017
LGC invests in new GMP analytical capability

News - The new labs comprise additional bioanalysis and synthetic chemistry labs as well as a new GMP CMC analytical capability for batch release testing of oligonucleotide-based drug substances

01 October 2018